Genotypic and Phenotypic Landscape of KBG Syndrome: A Study of 23 Turkish Individuals
Articles > Article · 2025
Authors: ENİSE AVCI, Esra IŞIK, Türkan Turkut Tan, YUSUF CAN DOĞAN, BANU NUR, BURCU YETER, ASLIHAN SANRI, DİLEK ULUDAĞ ALKAYA, ŞERİFE ÖZTÜRK YILMAZ, AKÇAHAN AKALIN, GİZEM ÜREL DEMİR, AYŞEGÜL YILMAZ, MERVE GÜVENOĞLU, ÖZNUR YILMAZ, ÖZLEM GİRAY BOZKAYA, ÖZLEM SEZER, PELİN ÖZLEM ŞİMŞEK KİPER, GÜLEN EDA ÜTİNE, BEYHAN TÜYSÜZ, Muhsin Özgür ÇOĞULU, ERCAN MIHÇI, Tahir ATİK
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, Journal Indexed in SCI Expanded, International, WoS, 2025, vol 197, pp 1-1
DOI: 10.1002/ajmg.a.64128
Summary
KBG syndrome is a rare autosomal dominant disorder caused by ANKRD11 variants, characterized by distinctive craniofacial features, short stature, skeletal anomalies, and neurodevelopmental impairment. Regional studies, particularly from underrepresented populations, are essential to broaden the clinical and molecular spectrum of the syndrome. We retrospectively analyzed the clinical, molecular, and anthropometric data of 23 Turkish individuals with molecularly confirmed KBG syndrome. Molecular analyses included whole exome sequencing, clinical exome sequencing, and targeted gene panels. Variants were classified according to ACMG guidelines, and phenotypic features were systematically assessed using standardized criteria. Eighteen distinct ANKRD11 pathogenic or likely pathogenic variants were identified, including eight novel variants, predominantly located in exon 9. Short stature (height SDS < -2) was documented in 30.4% of patients. Intellectual disability was observed in 82.6%, and behavioral anomalies in 52.2% of the cohort. Craniofacial dysmorphism, including long philtrum, triangular facial shape, and macrodontia, was prominent. No genotype-phenotype correlation could be established. This study expands the mutational landscape of ANKRD11 and underscores the clinical variability of KBG syndrome in a Turkish cohort. Our findings emphasize the importance of integrating molecular and detailed clinical evaluations for early diagnosis, especially in diverse populations with limited prior representation.